SG11202005297TA - Compounds for treating and preventing extracellular histone mediated pathologies - Google Patents
Compounds for treating and preventing extracellular histone mediated pathologiesInfo
- Publication number
- SG11202005297TA SG11202005297TA SG11202005297TA SG11202005297TA SG11202005297TA SG 11202005297T A SG11202005297T A SG 11202005297TA SG 11202005297T A SG11202005297T A SG 11202005297TA SG 11202005297T A SG11202005297T A SG 11202005297TA SG 11202005297T A SG11202005297T A SG 11202005297TA
- Authority
- SG
- Singapore
- Prior art keywords
- treating
- compounds
- mediated pathologies
- extracellular histone
- preventing extracellular
- Prior art date
Links
- 108010033040 Histones Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 230000007170 pathology Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017905024A AU2017905024A0 (en) | 2017-12-15 | Compounds for treating and preventing sepsis | |
| PCT/AU2018/051337 WO2019113645A1 (en) | 2017-12-15 | 2018-12-14 | Compounds for treating and preventing extracellular histone mediated pathologies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202005297TA true SG11202005297TA (en) | 2020-07-29 |
Family
ID=66818735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202005297TA SG11202005297TA (en) | 2017-12-15 | 2018-12-14 | Compounds for treating and preventing extracellular histone mediated pathologies |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11628179B2 (ko) |
| EP (1) | EP3723768A4 (ko) |
| JP (2) | JP7359396B2 (ko) |
| KR (1) | KR20200100083A (ko) |
| CN (3) | CN111479574B (ko) |
| AU (1) | AU2018382223A1 (ko) |
| BR (1) | BR112020013714A2 (ko) |
| CA (1) | CA3085374A1 (ko) |
| IL (1) | IL275414B2 (ko) |
| SG (1) | SG11202005297TA (ko) |
| WO (1) | WO2019113645A1 (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI744300B (zh) * | 2016-03-23 | 2021-11-01 | 里爾中央醫學中心 | 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途 |
| JP2022530732A (ja) * | 2019-02-25 | 2022-07-01 | ジ・オーストラリアン・ナショナル・ユニヴァーシティ | Ｎｅｔ関連合併症を処置及び予防するための化合物 |
| WO2022116981A1 (zh) * | 2020-12-01 | 2022-06-09 | 远大医药（中国）有限公司 | 一种聚阴离子纤维二糖苷类化合物的应用 |
| CN116813675B (zh) * | 2023-08-23 | 2023-11-24 | 北京远大九和药业有限公司 | 一种化合物晶型及其制备、组合物和用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3270960A (en) | 1964-09-11 | 1966-09-06 | Sperry Rand Corp | Fluid sensor |
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| CA2159649A1 (en) * | 1993-03-29 | 1994-10-13 | Queen's University At Kingston | Anticoagulant compounds |
| ZA949182B (en) * | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
| JPH09183789A (ja) | 1995-10-31 | 1997-07-15 | Sanwa Kagaku Kenkyusho Co Ltd | 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途 |
| ATE321882T1 (de) | 1997-07-01 | 2006-04-15 | Isis Pharmaceuticals Inc | Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre |
| US20060148732A1 (en) * | 2000-11-17 | 2006-07-06 | Gutterman Jordan U | Inhibition of NF-kappaB by triterpene compositions |
| CN1871015B (zh) * | 2003-10-24 | 2010-06-16 | 努特里奇亚有限公司 | 免疫调节性寡糖 |
| MXPA06007194A (es) | 2003-12-23 | 2007-01-19 | Progen Ind Ltd | Imitaciones de glicosaminoglican (gag). |
| JP5139797B2 (ja) | 2004-03-04 | 2013-02-06 | プロジェン ファーマシューティカルズ リミテッド | 硫酸化オリゴ糖誘導体 |
| GB0512726D0 (en) * | 2005-06-22 | 2005-07-27 | Btg Int Ltd | Multiple sclerosis therapy and diagnosis |
| WO2011163657A1 (en) * | 2010-06-25 | 2011-12-29 | E. I. Du Pont De Nemours And Company | Polyoxymethylene compositions with branched polymers |
| KR101956335B1 (ko) * | 2010-12-01 | 2019-03-08 | 디 오스트레일리언 내셔널 유니버시티 | 히스톤 억제 |
| GB201108891D0 (en) * | 2011-05-26 | 2011-07-13 | King S College London | Compounds which interact with histones |
| US9559939B2 (en) | 2013-03-15 | 2017-01-31 | Genesys Telecommunications Laboratories, Inc. | System and method for handling resource failure in a hybrid contact center operations environment |
| WO2017035357A1 (en) * | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Phosphonate compounds for treatment of medical disorders |
-
2018
- 2018-12-14 US US16/770,987 patent/US11628179B2/en active Active
- 2018-12-14 KR KR1020207018031A patent/KR20200100083A/ko not_active Application Discontinuation
- 2018-12-14 JP JP2020552068A patent/JP7359396B2/ja active Active
- 2018-12-14 CN CN201880080079.XA patent/CN111479574B/zh active Active
- 2018-12-14 EP EP18888652.7A patent/EP3723768A4/en active Pending
- 2018-12-14 CN CN202311361208.1A patent/CN117462563A/zh active Pending
- 2018-12-14 IL IL275414A patent/IL275414B2/en unknown
- 2018-12-14 WO PCT/AU2018/051337 patent/WO2019113645A1/en active Search and Examination
- 2018-12-14 CN CN202311361103.6A patent/CN117427084A/zh active Pending
- 2018-12-14 CA CA3085374A patent/CA3085374A1/en active Pending
- 2018-12-14 AU AU2018382223A patent/AU2018382223A1/en active Pending
- 2018-12-14 SG SG11202005297TA patent/SG11202005297TA/en unknown
- 2018-12-14 BR BR112020013714-6A patent/BR112020013714A2/pt unknown
-
2023
- 2023-02-06 US US18/106,138 patent/US20230255992A1/en active Pending
- 2023-07-18 JP JP2023116659A patent/JP2023153841A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL275414B1 (en) | 2023-12-01 |
| KR20200100083A (ko) | 2020-08-25 |
| CN117462563A (zh) | 2024-01-30 |
| JP2021517582A (ja) | 2021-07-26 |
| WO2019113645A1 (en) | 2019-06-20 |
| CN111479574A (zh) | 2020-07-31 |
| EP3723768A4 (en) | 2021-09-01 |
| US20210205343A1 (en) | 2021-07-08 |
| CN111479574B (zh) | 2024-02-09 |
| EP3723768A1 (en) | 2020-10-21 |
| IL275414A (en) | 2020-07-30 |
| JP7359396B2 (ja) | 2023-10-11 |
| BR112020013714A2 (pt) | 2020-12-01 |
| US11628179B2 (en) | 2023-04-18 |
| US20230255992A1 (en) | 2023-08-17 |
| IL275414B2 (en) | 2024-04-01 |
| CN117427084A (zh) | 2024-01-23 |
| CA3085374A1 (en) | 2019-06-20 |
| JP2023153841A (ja) | 2023-10-18 |
| AU2018382223A1 (en) | 2020-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201700991D0 (en) | Aneurysm treatment apparatus | |
| IL272989A (en) | Electrosurgical device | |
| IL275414A (en) | Compounds for the treatment of pathologies mediated by extracellular histones and their prevention | |
| ZA201807653B (en) | New tetrahydropyrimidodiazepin and dihydropyridodiazepin compounds for treating pain and pain related conditions | |
| GB201811679D0 (en) | Treatment apparatus | |
| HK1251449A1 (zh) | 用於治療2型糖尿病的交聯聚二烯丙基胺共聚物 | |
| IL275561A (en) | Electrosurgical device | |
| ZA202002526B (en) | New alcoxyamino derivatives for treating pain and pain related conditions | |
| GB2559010B (en) | Electrosurgical apparatus | |
| GB201719105D0 (en) | Orthopedic apparatus | |
| GB2546166B (en) | Electrosurgical apparatus | |
| EP3636712C0 (en) | FLUORORIC RUBBER COMPOSITION AND CROSS-LINKED FLUORORIC RUBBER PRODUCT | |
| SG10201913372QA (en) | Treatment apparatus | |
| GB201708725D0 (en) | Electrosurgical apparatus | |
| GB201705747D0 (en) | Electrosurgical apparatus | |
| GB201718985D0 (en) | Treatment | |
| GB201710461D0 (en) | Ophthalmological apparatus | |
| GB201713650D0 (en) | Treatment | |
| GB201706955D0 (en) | Treatment |